TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05567380 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT04872049 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05639218 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05639218 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04967599 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT05071807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06625112 — Predictive Biomarker (PRD): STXBP1 mRNA
Genes: STXBP1; UNC18A
Study NCT06682572 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06682572 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT06715436 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06718010 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06718010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00386659 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06109103 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05197556 — Predictive Biomarker (PRD): PON2 mRNA
Genes: PON2
Study NCT05115539 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06143644 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04990557 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04990557 — Predictive Biomarker (PRD): PDCD1 mRNA
Genes: PDCD1; PD1
Study NCT06405230 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06405230 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06402071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06745336 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05684289 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05684289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06220773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06121336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05822661 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06298019 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06298019 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06270810 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06270810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05722600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06008054 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT06064812 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06440369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05103722 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05103722 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05691413 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06141304 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05430802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05883176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04988178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04988178 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06746441 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06746441 — Safety Biomarker (SAF): BDNF
Study NCT06747585 — Predictive Biomarker (PRD): CLDN1 mRNA
Genes: CLDN1; CLD1; SEMP1; UNQ481/PRO944
Study NCT05909644 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06506656 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06143865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04898062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00001052 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06028126 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study NCT05702437 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05218551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06446011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06446011 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06747156 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06746571 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05935904 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05503017 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT06384027 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05989204 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05989204 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04728399 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04728399 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06276283 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05544448 — Predictive Biomarker (PRD): STAT5A mRNA
Genes: STAT5A; STAT5
Study NCT05544448 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05191342 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05710406 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05981092 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study NCT05057182 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05057182 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06048393 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04942899 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04942899 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04722887 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05254886 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study NCT05618197 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study NCT06001632 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06121453 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05178407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05175053 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05131022 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04274413 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06397729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06517953 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05962957 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT05962957 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05962957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05232162 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06291688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06085677 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06529250 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT05254821 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00001025 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06437496 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05937854 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05710978 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT04997694 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05431881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06613373 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06613373 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06613373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05784415 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05041257 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT04850521 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06409962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06556407 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05036759 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05343117 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05343117 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05561400 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT05561400 — Predictive Biomarker (PRD): F7 mRNA
Genes: F7
Study NCT05717946 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05717946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05717946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05439824 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05557786 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT05309408 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04983121 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04983121 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05324735 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05292742 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05469828 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05116371 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05282654 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06211985 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06316791 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05392140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05568836 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05568836 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05568836 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04863573 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06325800 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04487808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06304129 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04774432 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05251987 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05086523 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04735367 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04735367 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05412459 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06087120 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04081883 — Predictive Biomarker (PRD): DIABLO mRNA
Genes: DIABLO; SMAC
Study NCT06250595 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT06022939 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06139107 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06139107 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06139107 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05902520 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT05178888 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04874116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05952856 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06447740 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06487585 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT06487585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05269823 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05733598 — Predictive Biomarker (PRD): RP2 mRNA
Genes: RP2
Study NCT04117165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06555536 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT06167785 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05292508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06492317 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05060991 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06447701 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05540743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05434481 — Predictive Biomarker (PRD): MFN1 mRNA
Genes: MFN1
Study NCT05875337 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06504914 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04498520 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05374369 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study NCT06208683 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04718714 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04718714 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04718714 — Safety Biomarker (SAF): Interleukin 1
Study NCT06421701 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05173805 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04870190 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05007392 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05992519 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04938115 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04875182 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04997382 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05130892 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05130892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04823195 — Predictive Biomarker (PRD): GJB2 mRNA
Genes: GJB2
Study NCT05505812 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06382129 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05310370 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05310370 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05310370 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05585996 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05756452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05683964 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05694767 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05694767 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06505044 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06209177 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study NCT04927260 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT04927260 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04772885 — Safety Biomarker (SAF): Interleukin 1
Study NCT04745130 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04745130 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04745130 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05248048 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05963100 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT05474248 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05474248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05706532 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05752630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05116618 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05116618 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05116618 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04310943 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06385600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05192005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04916431 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04916431 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06545201 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06265246 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05649397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06497387 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05375370 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06340373 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT06124833 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT05279495 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05559996 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05556109 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT04930328 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05158309 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05549141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05115903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05219305 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06337266 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT06061536 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04508998 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00002005 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05935696 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05279183 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05279183 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03517098 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06259721 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00061178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05384574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05384574 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05384574 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05345171 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT05345171 — Surrogate Endpoint (SUR): Plasma ammonia
Study NCT04845165 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT04845165 — Predictive Biomarker (PRD): HSD11B1 mRNA
Genes: HSD11B1; HSD11; HSD11L; SDR26C1
Study NCT05733572 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04608643 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05749926 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06076265 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04770129 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06444971 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05970185 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06689839 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT04852731 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT02592941 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05648383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05214885 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT05214885 — Predictive Biomarker (PRD): NDUFA4L2 mRNA
Genes: NDUFA4L2
Study NCT05214885 — Predictive Biomarker (PRD): Angiopoietin-related protein 4
Genes: ANGPTL4; ARP4; HFARP; PGAR; PP1158; PSEC0166; UNQ171/PRO197
Study NCT05214885 — Predictive Biomarker (PRD): EGLN3 mRNA
Genes: EGLN3
Study NCT05214885 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06147362 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT06693466 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06718244 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19